Avril Dieser
Vermögen: 10 700 $ am 31.05.2026
Vermögen: 10 700 $ am 31.05.2026
Avril McKean Dieser is an Independent Non-Executive Director at OS Therapies, Inc. since 2024.
Ms. Dieser is Vice President & Head-Legal Patient Evidence at UCB, Inc. since 2016.
Ms. Dieser was a Member at AbbVie, Inc. from 2013 to 2016.
Ms. Dieser completed graduate degrees at the University of Maryland and Columbus School of Law, and an undergraduate degree at Duquesne University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.01.2026 | 5 000 ( 0,01 % ) | 10 700 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| OS THERAPIES INCORPORATED | Direktor/Vorstandsmitglied | 28.10.2024 |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 01.08.2016 |
| Unternehmen | Position | Ende |
|---|---|---|
| ABBVIE INC. | Corporate Officer/Principal | 01.07.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Columbus School of Law
Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OS Therapies, Inc.
OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen